|
Jubilant Pharmova to convene board meeting> |
|
Paras Defence and Space Technologies Ltd leads losers in 'A' group> |
|
Jubilant Pharmova consolidated net profit declines 44.60% in the December 2025 quarter> |
|
Jubilant Pharmova slips after weak Q3 performance> |
|
Jubilant Pharmova to declare Quarterly Results> |
|
Jubilant Pharmova appoints Daniel J. O'Connor as CEO of Jubilant Therapeutics Inc.> |
|
Board of Jubilant Pharmova approves grant of 1,506 stock options> |
|
Jubilant Pharmova consolidated net profit rises 17.02% in the September 2025 quarter> |
|
Jubilant Pharmova Ltd - Jubilant Pharmova Limited - Press Release> |
|
Jubilant Pharmova Ltd - Jubilant Pharmova Limited - Outcome of Board Meeting> |